Latest Production News

ikeGPS has reported a robust first half of FY26 with subscription revenue soaring 47%, a successful A$24 million capital raise, and inclusion in the ASX All Ordinaries Index, underscoring its expanding footprint in the US grid modernization market.

ikeGPS Group reports a robust first half of FY26 with a 47% increase in subscription revenue exit run rate and launches AI-driven PolePilot™ to boost productivity and ARPU.

Lion Rock Minerals has confirmed a major expansion of its mineralised footprint at the Minta Rutile and Monazite Projects in Cameroon, backed by significant funding rounds including a strategic partnership with Tronox Holdings. The company is well-positioned to accelerate exploration and resource definition into 2026.

Clarity Pharmaceuticals has responded to ASX queries clarifying the timing and materiality of its SAR-bisFAP data presentation, denying the information was price sensitive despite a notable share price rise.

Golden Dragon Mining Ltd is set to raise $5 million through an IPO, aiming for ASX listing with a portfolio of promising gold and nickel exploration projects in Western Australia.

Brazilian Critical Minerals has reported exceptional results from its in-situ recovery trials at the Ema rare earth project, achieving rare earth concentrations far exceeding in-situ grades and securing strong local government backing.

Matsa Resources has commenced mining at its Devon Pit Gold Mine, producing over 2,600 ounces of gold, while securing a $15 million funding package to accelerate development of its Lake Carey Gold Project.

Central Iron Ore Limited has filed an updated NI 43-101 Technical Report for its British King Gold Project in Western Australia, revealing a significant resource upgrade and confirming strong metallurgical performance.

Red Sky Energy reports steady production and cash flow growth from its Innamincka and Killanoola projects, while securing a strategic 35% stake in Angola’s Block 6/24, marking a significant step in its international expansion.

Cambium Bio has locked in a significant R&D tax rebate and forged three strategic partnerships, underpinning its Phase 3 clinical trials for its lead ophthalmology biologic. The company’s recent capital raise further strengthens its runway as it prepares for pivotal trial milestones.

Javelin Minerals has signed a pivotal Land Use Agreement with the Marlinyu Ghoorlie group and expanded its mining lease application, setting the stage for gold production at the Eureka Project by mid-2026.

Zelira Therapeutics has made significant progress in its HOPE 1 clinical trial program, completing a key FDA submission and securing a $650,000 non-dilutive R&D loan facility to support ongoing development and working capital needs.